# Imaging Cannabinoid CB1 Receptors in Schizophrenia

> **NCT01063335** · — · TERMINATED · sponsor: **National Institute of Mental Health (NIMH)** · enrollment: 1 (actual)

## Conditions studied

- Schizophrenia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01063335
- **Lead sponsor:** National Institute of Mental Health (NIMH)
- **Sponsor class:** NIH
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2010-02-01
- **Primary completion:** —
- **Final completion:** 2012-09-20
- **Target enrollment:** 1 (ACTUAL)
- **Last updated:** 2018-07-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01063335

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01063335, "Imaging Cannabinoid CB1 Receptors in Schizophrenia". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01063335. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*